Cargando…
Effect of desipramine on patients with breathing disorders in RETT syndrome
OBJECTIVE: Rett Syndrome (RTT) is a severe neurodevelopmental condition with breathing disorders, affecting around one in 10,000 female births. Desipramine, a noradrenaline reuptake inhibitor, reduced the number of apneas in Mecp2‐deficient mice, a model of RTT. We planned a phase 2 trial to test it...
Autores principales: | Mancini, Josette, Dubus, Jean‐Christophe, Jouve, Elisabeth, Roux, Jean‐Christophe, Franco, Patricia, Lagrue, Emmanuelle, Castelnau, Pierre, Cances, Claude, Chaix, Yves, Rougeot‐Jung, Christelle, Cornu, Catherine, Desportes, Vincent, Vallée, Louis, Bahi‐Buisson, Nadia, Truillet, Romain, Attolini, Laurence, Villard, Laurent, Blin, Olivier, Micallef, Joëlle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817841/ https://www.ncbi.nlm.nih.gov/pubmed/29468173 http://dx.doi.org/10.1002/acn3.468 |
Ejemplares similares
-
Rett syndrome: think outside the (skull) box
por: Borloz, Emilie, et al.
Publicado: (2021) -
Rett syndrome from bench to bedside: recent advances
por: Ehinger, Yann, et al.
Publicado: (2018) -
What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps?
por: Lacroix, Clémence, et al.
Publicado: (2022) -
Cell cloning-based transcriptome analysis in Rett patients: relevance to the pathogenesis of Rett syndrome of new human MeCP2 target genes
por: Nectoux, J, et al.
Publicado: (2010) -
Anti-inflammatory properties of desipramine and fluoxetine
por: Roumestan, Caroline, et al.
Publicado: (2007)